Profile data is unavailable for this security.
About the company
ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.
- Revenue in USD (TTM)455.22m
- Net income in USD-51.16m
- Incorporated2021
- Employees2.60k
- LocationZimVie Inc10225 Westmoor DriveWESTMINSTER 80021United StatesUSA
- Phone+1 (303) 443-7500
- Websitehttps://www.zimvie.com/en
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AxoGen Inc | 163.73m | -21.28m | 298.50m | 426.00 | -- | 3.20 | -- | 1.82 | -0.4943 | -0.4943 | 3.80 | 2.13 | 0.8709 | 1.49 | 7.04 | 384,333.30 | -11.32 | -13.92 | -12.82 | -15.84 | 78.34 | 79.74 | -13.00 | -20.28 | 2.23 | -8.76 | 0.3346 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Tactile Systems Technology Inc | 276.67m | 28.19m | 302.49m | 992.00 | 10.76 | 1.56 | 8.71 | 1.09 | 1.18 | 1.18 | 11.70 | 8.14 | 1.01 | 6.77 | 6.05 | 278,896.20 | 10.30 | 0.9015 | 12.18 | 1.09 | 49.98 | 49.10 | 10.19 | 0.8309 | 3.63 | -- | 0.128 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
| Zynex Inc | 188.68m | 8.17m | 322.52m | 1.10k | 44.89 | 9.93 | 25.50 | 1.71 | 0.2261 | 0.2261 | 5.39 | 1.02 | 1.59 | 2.52 | 6.56 | 171,530.00 | 6.89 | 14.58 | 8.41 | 17.52 | 80.22 | 79.62 | 4.33 | 10.44 | 2.87 | 7.24 | 0.6381 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
| Sight Sciences Inc | 81.50m | -54.75m | 326.40m | 214.00 | -- | 2.98 | -- | 4.01 | -1.12 | -1.12 | 1.67 | 2.20 | 0.4628 | 1.66 | 5.09 | 380,822.40 | -31.09 | -38.78 | -33.65 | -42.20 | 85.73 | 80.74 | -67.18 | -105.14 | 12.42 | -14.76 | 0.2358 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Nevro Corp | 430.75m | -82.59m | 343.41m | 1.22k | -- | 1.23 | -- | 0.7973 | -2.28 | -2.28 | 11.90 | 7.59 | 0.736 | 1.14 | 6.04 | 354,523.50 | -14.11 | -13.64 | -16.06 | -16.68 | 68.94 | 68.54 | -19.17 | -20.67 | 5.57 | -- | 0.4354 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| Treace Medical Concepts Inc | 196.03m | -54.75m | 364.61m | 516.00 | -- | 2.88 | -- | 1.86 | -0.8885 | -0.8885 | 3.18 | 2.04 | 0.797 | 1.28 | 7.07 | 379,905.00 | -22.26 | -- | -25.98 | -- | 80.99 | -- | -27.93 | -- | 3.22 | -- | 0.2958 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Jin Medical International Ltd | 19.82m | 2.88m | 428.94m | 245.00 | 138.17 | 17.82 | 138.18 | 21.64 | 0.0198 | 0.0198 | 0.1414 | 0.1538 | 0.7363 | 2.21 | 4.77 | 80,903.92 | 10.69 | 12.81 | 14.68 | 20.92 | 34.23 | 33.58 | 14.52 | 14.60 | 2.92 | -- | 0.1464 | 0.00 | 3.29 | -1.07 | 6.34 | -4.80 | -9.50 | -- |
| ZimVie Inc | 455.22m | -51.16m | 454.36m | 2.60k | -- | 1.17 | -- | 0.9981 | -1.92 | -14.01 | 17.11 | 14.24 | 0.3299 | 1.09 | 3.73 | 175,085.40 | -3.71 | -- | -4.28 | -- | 63.05 | 65.51 | -11.24 | -8.73 | 2.23 | -0.343 | 0.5673 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| MaxCyte Inc | 44.05m | -36.57m | 468.36m | 143.00 | -- | 2.07 | -- | 10.63 | -0.3532 | -0.3532 | 0.4253 | 2.17 | 0.1633 | 0.463 | 5.77 | 308,067.80 | -13.56 | -13.18 | -14.36 | -14.33 | 88.32 | 88.79 | -83.01 | -62.96 | 12.37 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
| Nano-X Imaging Ltd | 10.01m | -61.26m | 483.11m | 164.00 | -- | 2.61 | -- | 48.26 | -1.08 | -1.08 | 0.1755 | 3.20 | 0.045 | -- | 7.28 | 61,042.68 | -27.54 | -30.98 | -30.10 | -35.10 | -71.15 | -- | -611.89 | -1,527.24 | 5.59 | -- | 0.0177 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| Pacific Biosciences of California Inc | 200.43m | -296.90m | 487.52m | 796.00 | -- | 0.751 | -- | 2.43 | -1.14 | -1.14 | 0.7695 | 2.38 | 0.1124 | 2.21 | 6.69 | 251,797.70 | -16.65 | -16.19 | -18.40 | -17.81 | 28.81 | 37.35 | -148.13 | -136.21 | 8.36 | -21.84 | 0.5791 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Orthofix Medical Inc | 760.05m | -126.48m | 515.28m | 1.63k | -- | 0.9006 | -- | 0.678 | -3.40 | -3.40 | 20.42 | 15.24 | 0.8338 | 1.16 | 6.36 | 465,143.80 | -13.87 | -8.88 | -16.48 | -10.96 | 66.20 | 72.37 | -16.64 | -9.28 | 1.19 | -8.38 | 0.194 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Bioventus Inc | 522.74m | -21.65m | 532.62m | 995.00 | -- | 3.10 | 20.87 | 1.02 | -0.3438 | -0.3438 | 8.30 | 2.16 | 0.6217 | 1.95 | 4.28 | 538,910.30 | -3.23 | -5.52 | -4.47 | -7.27 | 65.55 | 68.25 | -5.20 | -10.94 | 0.9745 | 1.03 | 0.6428 | -- | 0.0445 | 9.93 | 6.91 | -- | 23.51 | -- |
| Iradimed Corp | 67.69m | 17.92m | 537.85m | 148.00 | 30.18 | 7.07 | 28.71 | 7.95 | 1.41 | 1.41 | 5.31 | 6.01 | 0.8273 | 1.67 | 5.51 | 457,333.40 | 21.91 | 13.16 | 24.02 | 14.58 | 76.57 | 76.55 | 26.48 | 21.46 | 7.77 | -- | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| SI-Bone Inc | 144.05m | -43.12m | 578.93m | 344.00 | -- | 3.49 | -- | 4.02 | -1.08 | -1.08 | 3.61 | 4.03 | 0.7728 | 1.62 | 6.44 | 418,735.50 | -23.13 | -27.88 | -25.72 | -30.94 | 78.10 | 85.03 | -29.93 | -51.09 | 8.75 | -- | 0.1791 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Surmodics Inc | 142.96m | 13.50m | 599.78m | 376.00 | 43.83 | 4.84 | 26.97 | 4.20 | 0.9597 | 0.9597 | 10.14 | 8.69 | 0.8194 | 2.05 | 6.66 | 380,220.80 | 7.74 | -1.85 | 8.69 | -2.18 | 79.11 | 82.93 | 9.44 | -2.98 | 3.59 | 9.66 | 0.1921 | -- | 32.65 | 10.27 | 94.37 | -- | -27.02 | -- |
Data as of May 31 2024. Currency figures normalised to ZimVie Inc's reporting currency: US Dollar USD
49.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Camber Capital Management LPas of 31 Mar 2024 | 3.25m | 12.00% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.64m | 6.07% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 1.58m | 5.85% |
| Neuberger Berman Investment Advisers LLCas of 31 Mar 2024 | 1.44m | 5.30% |
| Divisadero Street Capital Management LPas of 31 Mar 2024 | 1.27m | 4.70% |
| Kent Lake Capital LLCas of 31 Mar 2024 | 1.00m | 3.69% |
| Dimensional Fund Advisors LPas of 31 Mar 2024 | 998.22k | 3.69% |
| Charles Schwab Investment Management, Inc.as of 31 Mar 2024 | 732.86k | 2.71% |
| J. Goldman & Co. LPas of 31 Mar 2024 | 703.47k | 2.60% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 674.37k | 2.49% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
